WELL Health Technologies Corp. (TSE:WELL) Receives C$6.97 Consensus Target Price from Brokerages

Shares of WELL Health Technologies Corp. (TSE:WELL) have been assigned an average rating of “Moderate Buy” from the seven analysts that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is C$6.97.

A number of equities research analysts have recently weighed in on WELL shares. CIBC boosted their price target on WELL Health Technologies from C$4.75 to C$5.00 in a research note on Friday, August 16th. Ventum Financial dropped their target price on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th.

WELL Health Technologies Stock Up 2.7 %

WELL Health Technologies stock opened at C$4.52 on Thursday. The business has a fifty day moving average price of C$4.42 and a 200-day moving average price of C$4.30. WELL Health Technologies has a 1-year low of C$3.41 and a 1-year high of C$5.05. The stock has a market capitalization of C$1.13 billion, a price-to-earnings ratio of 7.93, a PEG ratio of -1.93 and a beta of 1.20. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.